Alkyl Amines Chemicals Limited reported a flat performance for FY26, with both top-line and bottom-line figures remaining relatively unchanged from the previous year. Management attributed the results to a challenging year marked by the impact of global conflict on raw material prices and logistics. The company remains cautiously optimistic, focusing on market share retention, strategic capacity utilization, and a disciplined approach to future investments amidst ongoing market volatility.
Annual Financial Performance
During the FY26 earnings call, leadership highlighted that the fiscal year was largely flat, with both revenue and profit experiencing a variance of only plus or minus 1% compared to the previous year. While volume and value were steady, the company noted that raw material prices, particularly for ammonia, saw significant spikes, rising from approximately INR 50 per kg to over INR 100 per kg. The company successfully passed these cost increases to customers, noting that their products often represent a minor cost component for end-users, facilitating easier price absorption.
Strategic Outlook and Market Dynamics
Management expressed cautious optimism regarding future growth. With the impact of global supply chain disruptions beginning to stabilize, the company anticipates a return to normal growth rates of 5% to 10% in the coming year. Addressing competition, leadership highlighted that while Chinese imports remain present, their aggressive pricing strategies have softened, providing some relief to domestic manufacturers. The company continues to prioritize maintaining its market share across its primary segments, which include pharma (50%–60% of sales) and agro (15%–20% of sales).
Capex and Operational Status
Regarding project expansion, the company confirmed that the project in Kurkumbh is facing a minor delay, with mechanical completion now expected by the end of June 2026. Capital expenditure for FY27 and FY28 is projected to be between INR 80 crore and INR 90 crore, primarily dedicated to completing current projects and routine maintenance. Management emphasized a disciplined approach to new investments, stating that they will evaluate new R&D-driven product opportunities only after market volatility subsides.
Capacity and Segment Overview
The company confirmed that it possesses 30,000 tons of capacity for acetonitrile and has sufficient capacity for ethylamines to meet demand for the next 4 to 5 years. In the methylamines segment, leadership noted an industry-wide overcapacity following the entry of new players. Operating at 60% to 85% capacity utilization across its plants, Alkyl Amines believes its focus on cost efficiency will maintain its competitive edge in the global market.
Source: BSE
